BAROLDI, P.
13  results:
Search for persons X
?
 
?
2

Efficacy and safety of extended‐release oxcarbazepine (Oxte..:

French, J.A. ; Baroldi, P. ; Brittain, S.T...
Acta Neurologica Scandinavica.  129 (2013)  3 - p. 143-153 , 2013
 
?
3

Efficacy and Tolerability of SPN-804, a Novel, Once-Daily E..:

Baroldi, P. ; Brittain, S. ; Louro, D..
Neurology.  78 (2012)  Meeting Abstracts 1 - p. P06.101-P06.101 , 2012
 
?
4

Oxcarbazepine Extended-Release (SPN-804) Therapy in Patient..:

Johnson, J. ; Brittain, S. ; Keeler, E...
Neurology.  78 (2012)  Meeting Abstracts 1 - p. P06.107-P06.107 , 2012
 
?
5

Evaluation of personality as a component of the healthy con..:

Berto, D. ; Milleri, S. ; Squassante, L..
European Journal of Clinical Pharmacology.  51 (1996)  3-4 - p. 209-213 , 1996
 
?
6

Looking for healthy volunteers:

Baroldi, P.A. ; Capriati, A. ; Gambini, F..
Pharmacological Research.  31 (1995)  - p. 2 , 1995
 
?
7

Prolactin-Lowering Effect of Acute and Once Weekly Repetiti..:

MATTEI, A. M. ; FERRARI, C. ; BAROLDI, P....
The Journal of Clinical Endocrinology & Metabolism.  66 (1988)  1 - p. 193-198 , 1988
 
?
8

The binding profile of octylonium bromide:

Barone, D. ; Maggi, C.A. ; Baroldi, P..
Pharmacological Research Communications.  20 (1988)  - p. 20 , 1988
 
?
9

Inhibition of Basal and Metoclopramide-Induced Prolactin Re..:

PONTIROLI, A. E. ; CAMMELLI, L. ; BAROLDI, P..
The Journal of Clinical Endocrinology & Metabolism.  65 (1987)  5 - p. 1057-1059 , 1987
 
?
12

Pharmacokinetic enhancement of inhibitors of the human immu..:

Kempf, D J ; Marsh, K C ; Kumar, G...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC163767.  , 1997
 
?
 
1-13